Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,260.00p
   
  • Change Today:
    -44.00p
  • 52 Week High: 1,634.00
  • 52 Week Low: 820.00
  • Currency: UK Pounds
  • Shares Issued: 86.13m
  • Volume: 99,083
  • Market Cap: £1,085.19m
  • RiskGrade: 125
  • Beta: 0.73

Oxford Biomedica ups revenue forecast as AstraZeneca lifts vaccine output

By Frank Prenesti

Date: Tuesday 18 May 2021

LONDON (ShareCast) - (Sharecast News) - Gene and cell therapy group Oxford Biomedica on Tuesday doubled annual earnings guidance after pharmaceutical giant AstraZeneca ordered more Covid-19 vaccines.
Oxford Biomedica, which has an 18-month supply deal with AstraZeneca to make its AZD1222 vaccine, lifted forecasts for expected cumulative revenues to more than £100m by end-2021 from more than £50m.

As a result, Oxford Biomedica said it expected 'significant growth' in annual operating earnings for the year to end-December.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 1,260.00p
Change Today -44.00p
% Change -3.37 %
52 Week High 1,634.00
52 Week Low 820.00
Volume 99,083
Shares Issued 86.13m
Market Cap £1,085.19m
Beta 0.73
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
72.73% below the market average72.73% below the market average72.73% below the market average72.73% below the market average72.73% below the market average
64% below the sector average64% below the sector average64% below the sector average64% below the sector average64% below the sector average
Price Trend
83.57% above the market average83.57% above the market average83.57% above the market average83.57% above the market average83.57% above the market average
70.00% above the sector average70.00% above the sector average70.00% above the sector average70.00% above the sector average70.00% above the sector average
Income Not Available
Growth
49.93% above the market average49.93% above the market average49.93% above the market average49.93% above the market average49.93% above the market average
23.53% above the sector average23.53% above the sector average23.53% above the sector average23.53% above the sector average23.53% above the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 5
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 03-Dec-2021

Time Volume / Share Price
16:35 20,149 @ 1,260.00p
16:29 13 @ 1,266.00p
16:29 75 @ 1,266.00p
16:29 1 @ 1,266.00p
16:29 24 @ 1,266.00p

OXB Key Personnel

CEO John Dawson
CFO Stuart Paynter

Top of Page